IMATINIB ZENITH 100 MG
imatinib
Public price
963,00 MAD
Active substance
imatinib
Laboratory
ZENITH PHARMA
What is this medicine?
Imatinib mesylate is a kinase inhibitor indicated for the treatment of various types of leukemia, myeloproliferative diseases, and specific stromal tumors.
Verified summary
imatinib, Comprimé pelliculé, 100 MG, Boite de 30
Common uses
Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML),Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL),Myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with platelet-derived growth factor receptor (PDGFR) gene re-arrangements,Aggressive systemic mastocytosis (ASM),Hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL),Unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans (DFSP),Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST),Adjuvant treatment following resection of Kit (CD117) positive GIST
Class
kinase inhibitor
Laboratory
ZENITH PHARMA
Hospital price
682,00 MAD
Strength
100 MG
Form
Comprimé pelliculé
Presentation
Boite de 30
ATC code
L01XE01
Type
Générique
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 963,00 MAD
Available presentations and strengths
Medicines with the same active substance
GLIVEC 400MG
400 MG · 1 BOITE 30 COMPRIME PELLICULE
0,00 MAD
CEMIVIL 100 MG
100 MG · Boite de 30
848,00 MAD
CEMIVIL 400 MG
400 MG · Boite de 30
2.010,00 MAD
IMATINIB COOPER 100 MG
100 MG · Boîte de 120
3.500,00 MAD
IMATEC 100 MG
100 MG · Boîte de 120
3.503,00 MAD
IMATEC
100 MG · 1 BOITE 120 GELULE
3.800,00 MAD
IMATINIB COOPER
100 MG · 1 BOITE 120 GELULE
3.800,00 MAD
GLIVEC 100 MG
100 MG · Boîte de 60
6.837,00 MAD
GLIVEC 100 MG
100 MG · Boîte de 120
11.761,00 MAD
GLIVEC
100 MG · 1 BOITE 60 COMPRIME PELLICULE
11.940,00 MAD
GLIVEC
100 MG · 1 BOITE 120 GELULE
20.399,00 MAD